DGCI Gives Nod For BharatBiotech’s Intranasal Booster Dose Trials In India
New Delhi: The Drugs Controller General of India (DCGI) has given permission to BharatBiotech for its intranasal booster dose trials. The trials will be done at 900 different sites.
The intranasal vaccines reportedly have the potential…